SCHEMBL575779

SCHEMBL575779

CCP(C)(=O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191734 0.78
SCHEMBL575409 0.78
SCHEMBL10786969 0.78
SCHEMBL14867528 0.78 GABBR2 (0.35)
SCHEMBL14168887 0.78
SCHEMBL13305910 0.78
SCHEMBL84049 0.76
SCHEMBL1317106 0.75
Ammonia Solution, Strong SCHEMBL2354177 0.75
SCHEMBL191930 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403642-B1 METHODS OF USING A SELECTIVE HYDROGENATION CATALYST CHEVRON PHILLIPS CHEMICAL CO LP (US) 2017-08-02 EP claimed
US-6376548-B1 FUNGICIDES; HERBICIDES; INSECTICIDES ROHM AND HAAS COMPANY 2002-04-23 US claimed
EP-0733055-A1 2-SPIRO(2'-SPIROCYCLOALKYL)CYCLOPROPYL CEPHALOSPORIN SULFONES AS ANTIINFLAMMATORY AND ANTIDEGENERATIVE AGENTS SYNPHAR LABORATORIES INC. (CA) 1996-09-25 EP claimed
US-5439904-A Enzyme inhibitors of human leukocyte elastase; respiratory system disorders; antiarthritic agents SYNPHAR LABORATORIES, INC. (CA) 1995-08-08 US claimed
WO-1995015966-A1 2-SPIRO(2'-SPIROCYCLOALKYL)CYCLOPROPYL CEPHALOSPORIN SULFONES AS ANTIINFLAMMATORY AND ANTIDEGENERATIVE AGENTS SYNPHAR LABORATORIES, INC. (CA) 1995-06-15 WO claimed
EP-0371721-B1 Preparation process for aromatic hydroxycarboxylic acid MITSUI TOATSU CHEMICALS (JP) 1994-07-27 EP claimed
US-4950781-A REACTING AN ALKALI METAL MALT OF PHENOL WITH CARBON DI OXIDE IN PRESENCE OF PHOSPHINE OXIDE SOLVENT MITSUI TOATSU CHEMICALS, INC. (JP) 1990-08-21 US claimed
EP-0371721-A2 Preparation process for aromatic hydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-06-06 EP claimed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
CN-115911573-A Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2023-04-04 CN disclosed
US-11616253-B2 Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-03-28 US disclosed
CN-110177788-B Compounds as BCL-2 selective apoptosis inducers 重庆复创医药研究有限公司 2023-03-24 CN disclosed
US-20220278370-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2022-09-01 US disclosed
EP-0478197-A1 Control process of isomer ratio of aromatic hydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-04-01 EP disclosed
US-4999356-A Analgesics, antidepressants, anticonvulsants HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-03-12 US disclosed
US-4950781-A REACTING AN ALKALI METAL MALT OF PHENOL WITH CARBON DI OXIDE IN PRESENCE OF PHOSPHINE OXIDE SOLVENT MITSUI TOATSU CHEMICALS, INC. (JP) 1990-08-21 US disclosed
EP-0371721-A2 Preparation process for aromatic hydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-06-06 EP disclosed
EP-0302423-A2 1-Phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-02-08 EP disclosed
US-3997611-A Production of tertiary phosphine oxides HOECHST AKTIENGESELLSCHAFT (DT) 1976-12-14 US disclosed